The infectious diseases specialists at UT Southwestern Medical Center are recognized authorities in the diagnosis and treatment of AIDS, HIV, hepatitis, meningitis, pneumonia, sexually transmitted diseases and other conditions. Combining expert and compassionate care with state-of-the-art medical resources, UT Southwestern provides advanced health-care services that make a difference in patients’ lives.

The infectious diseases service at UT Southwestern offers skilled management of AIDS and HIV and provides advanced testing, treatments and monitoring for patients. We also provide AIDS and HIV counseling, nutritional consultations and social work services to assist patients in all aspects of their health care and quality of life. UT Southwestern offers supplementary AIDS testing to determine the type of HIV strain causing the patient’s infection. Using the test results, our specialists tailor therapies using combinations of treatments designed for specific HIV strains.

UT Southwestern’s clinicians work in unison with our researchers to provide patients with the most effective therapies available to treat infectious diseases. Our program provides vital treatments for infection in patients with immune deficiencies, including individuals taking corticosteroids and transplant patients. Our infectious diseases service also provides effective treatments for patients with post-surgical infections, complex or recurrent urinary tract infections, respiratory tract infections such as pneumonia and sinusitis, skin infections, tuberculosis and other mycobacterial infections.

UT Southwestern is privileged to receive substantial research funding from the National Institutes of Health (NIH) and other prominent organizations to investigate new therapies for all types of infectious diseases.

Exemplifying our leadership in advancing the science of infectious diseases, UT Southwestern has received significant funding from the NIH to help create advanced medical-information resources to assist researchers investigating infectious diseases and immune disorders. The initiatives take advantage of information technology and databases to enable researchers to more rapidly develop new drugs and vaccines.